Cook Islands vs Tanzania, United Republic of: HPV vaccination coverage in 15-year-olds
Cook Islands
97.0%
in 2024
Tanzania, United Republic of
99.0%
in 2024
Cook Islands rank
5th
Tanzania, United Republic of rank
1st
HPV vaccination coverage in 15-year-olds over time
- Cook Islands
- Tanzania, United Republic of
How they compare
Tanzania, United Republic of currently reports 99.0% against 97.0% in Cook Islands, a difference of 2.0%.
The two have swapped places 1 time across 6 shared years of data; in 2019 it was Cook Islands ahead.
Cook Islands ranks 5th and Tanzania, United Republic of ranks 1st of 74 countries.
Across the 2 decades both report, Cook Islands averaged higher in 1 and Tanzania, United Republic of in 1.
Head to head by decade
| Decade | Cook Islands | Tanzania, United Republic of | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 99.0% | 47.0% | 52.0% | Cook Islands |
| 2020s | 77.0% | 80.8% | 3.8% | Tanzania, United Republic of |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hpv vaccination coverage in 15-year-olds, Cook Islands or Tanzania, United Republic of?
- Tanzania, United Republic of, at 99.0% against 97.0% in Cook Islands as of 2024.
- What is the difference in hpv vaccination coverage in 15-year-olds between Cook Islands and Tanzania, United Republic of?
- 2.0%, with Tanzania, United Republic of ahead.
- How many years of comparable data are there for Cook Islands and Tanzania, United Republic of?
- 6 years are reported by both, from 2019 to 2024.
- How do Cook Islands and Tanzania, United Republic of rank globally for hpv vaccination coverage in 15-year-olds?
- Cook Islands ranks 5th and Tanzania, United Republic of ranks 1st of 74 countries.
- Where does this data come from?
- WHO & UNICEF (2025) – processed by Our World in Data, published as HPV vaccination coverage in 15-year-olds. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Share of 15-year-olds who received doses of the human papillomavirus vaccine between the ages of 9 and 14.